Acquisition Closed September 11, 2026
Crinetics Pharmaceuticals, Inc. acquisition by Vertex Pharmaceuticals Incorporated (closed): stock options and RSUs
Completed: SEC filings show this deal closed by September 11, 2026. Vertex bought Crinetics for $85.00 per share in cash.
- Buyer
- Vertex Pharmaceuticals Incorporated
- What holders receive
- $85.00 per share in cash
- Agreement signed
- July 6, 2026
- Shareholder vote
- —
- Expected closing
- Not stated in the filing
- Closed
- September 11, 2026
How equity awards are treated
| Options priced above the deal | cancelled for no payment (likely) |
|---|
Estimate your payout at $85.00 per share
Options pay the spread between the deal price and the exercise price; options priced at or above $85.00 usually pay nothing. Whether unvested awards pay now or later depends on the treatment above. Before taxes.
What this means for your taxes
- Shares you own outright are sold for cash at closing. That is a taxable sale: the gain over your cost basis is a capital gain, long-term if you have held the shares more than a year at closing. For shares from vested RSUs, your basis is generally the value already taxed at vesting (it was on your W-2).
- ESPP shares sold in the deal within 2 years of the offering date or 1 year of purchase are a disqualifying disposition: part of the gain is taxed as ordinary income.
General rules, not advice for your situation. Your award agreement and the merger agreement control. Full guide: stock options and RSUs in an acquisition →
Source
From the company's SEC filing: DEFM14A (accession 0001140361-26-030500). Last checked against the filing on November 19, 2026. Found an error? Corrections are made the same day; see how we check.
Questions
What will Crinetics Pharmaceuticals, Inc. shareholders receive?
Under the merger agreement, holders receive $85.00 per share in cash.
What happens to Crinetics Pharmaceuticals, Inc. stock options and RSUs?
Options priced above the deal: cancelled for no payment (likely)
When will the deal close?
The filing does not give a specific closing date; closing depends on approvals. SEC filings show it closed by September 11, 2026.